Cancer Survival Analysis
Assumptions of Survival Analysis
Confounding in Epidemiological Studies
Comparing the Survival Analysis of Two or More Groups
Cancer-Critical Genes II: Tumor Suppressor Genes
Censoring Survival Data
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Sep 13, 2025

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
Siqiong Zhou1, Upala J Islam1, Nicholaus Pfeiffer2
1School of Computing and Augmented Intelligence, Arizona State University.
This study introduces Sparse CounteRGAN (SCGAN) to understand how imaging, clinical, and molecular (ICM) features influence breast cancer treatment response after neoadjuvant systemic therapy (NST). SCGAN generates realistic, sparse, and diverse counterfactuals for causal inference.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: